Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 08, 2020 16:05 ET | Source: Neuronetics

Neuronetics Announces the Amendment of Credit Facility with Solar Capital Partners

MALVERN, Pa., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
November 30, 2020 16:05 ET | Source: Neuronetics

Neuronetics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

MALVERN, Pa., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
November 23, 2020 16:05 ET | Source: Neuronetics

Neuronetics® Receives FDA Clearance for Three-Minute TouchStar™ Treatment Protocol

MALVERN, Pa., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
November 12, 2020 16:05 ET | Source: Neuronetics

Neuronetics to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum

MALVERN, Pa., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
November 02, 2020 16:05 ET | Source: Neuronetics

Neuronetics Reports Third Quarter 2020 Financial and Operating Results

MALVERN, Pa., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
October 19, 2020 16:05 ET | Source: Neuronetics

Neuronetics to Report Third Quarter 2020 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
October 13, 2020 08:00 ET | Source: Neuronetics

Journal of Affective Disorders Publishes Clinical Data Suggesting NeuroStar® Advanced Therapy as a First-line Treatment for Major Depressive Disorder

MALVERN, Pa., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
October 05, 2020 08:00 ET | Source: Neuronetics

Neuronetics Appoints Sara Grubbs as Vice President, Sales

MALVERN, Pa., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on improving the lives of patients who suffer from psychiatric...
October 01, 2020 08:00 ET | Source: Neuronetics

NeuroStar® Advanced Therapy Providers Offer Free TMS Consultations During National Depression Awareness Month

MALVERN, Pa., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
September 29, 2020 08:00 ET | Source: Neuronetics

Neuronetics® Celebrates 500,000 Treatment Milestone for Greenbrook® TMS

MALVERN, Pa., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...